News & Articles

New line of bioreactors is designed to ensure seamless scalability from early process development to commercial manufacturing

Panel designed to provide surveillance of ongoing mutations of virus that causes COVID-19

The first 510(K)-cleared transport medium for COVID-19 testing

Once considered a vestigial organelle, primary cilia are now believed to have an important function in the central nervous system

Newly FDA-approved system allows a patient to both communicate with a physician and remotely receive stimulation settings in real time regardless of location

How blood culture diagnostics are enabling accurate pathogen identification, resistance detection, and timely therapy

IL-6 assay aids in care management by determining patients at risk for intubation with mechanical ventilation

Explore topics including multiplexed assays, high-sensitivity troponin, 3D high-resolution X-ray microscopy, CRISPR, and Optimer reagents

Catch up on this on-demand webinar to explore potential biomarkers for COVID-19 severity and learn how the early assessment of viral load in plasma could improve patient care

With this partnership, Repositive is expanding its personalized medicine capabilities to support more biopharma customers

The heart has a ‘natural backup pacemaker’ that can kick into action if the primary way the organ generates electrical signals fails

Avacta’s AffiDX SARS-CoV-2 lateral flow test detects both B117 ‘Kent’ and D614G variants of the virus

New service supports UK government test-to-release scheme for day 2 testing

The test helps save on much-needed testing supplies since it allows for testing for all four viruses with one swab

Industry experts share insights on the elegant technology behind immunoassays and the critical raw materials that make them powerful

Simple, powerful user experience combines with reliability and scalability allowing users to focus on experimental results instead of process

For the first time Astronomy and Pathology (AstroPath™) come together to discover and clinically validate new spatial phenotypic signatures using multiplex immunofluorescence